NMD Pharma late breaking oral presentation at the MDA Conference with top-line safety and ...

NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravisAarhus, ...